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Abstract
Using two clinical samples of patients, the presented studies examined the construct validity of the recently revised Anxiety 
Sensitivity Index-3 (ASI-3). Confirmatory factor analyses established a clear three-factor structure that corresponds to the 
postulated subdivision of the construct into correlated somatic, social, and cognitive components. Participants with different 
primary clinical diagnoses differed from each other on the ASI-3 subscales in theoretically meaningful ways. Specifically, 
the ASI-3 successfully discriminated patients with anxiety disorders from patients with nonanxiety disorders. Moreover, 
patients with panic disorder or agoraphobia manifested more somatic concerns than patients with other anxiety disorders 
and patients with nonanxiety disorders. Finally, correlations of the ASI-3 scales with other measures of clinical symptoms 
and negative affect substantiated convergent and discriminant validity. Substantial positive correlations were found between 
the ASI-3 Somatic Concerns and body vigilance, between Social Concerns and fear of negative evaluation and socially 
inhibited behavior, and between Cognitive Concerns and depression symptoms, anxiety, fear of negative evaluation, and 
subjective complaints. Moreover, Social Concerns correlated negatively with dominant and intrusive behavior. Results are 
discussed with respect to the contribution of the ASI-3 to the assessment of anxiety-related disorders.
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Anxiety sensitivity ( AS) denotes the tendency to fear anxiety- 
related sensations, arising from beliefs that these sensations 
carry a risk for aversive consequences (Reiss, 1991). AS is 
a stable but malleable multidimensional personality trait 
(Armstrong, Khawaja, & Oei, 2006; Schmidt et al., 2007), 
encompassing fears of somatic, social, and cognitive conse­
quences of anxiety (Reiss, 1991; Taylor et al., 2007). Reiss 
(1991) proposed that AS may act as a dispositional ampli­
fier of fear, anxiety, and panic reactions, thereby contrib­
uting to the development and maintenance of anxiety 
pathology. Subsequent research demonstrated that AS is 
indeed substantially related to state and trait measures of 
fear, anxiety, and behavioral avoidance in clinical as well as 
in nonclinical samples (Eifert, Zvolensky, Sorrell, Hopko, 
& Lejuez, 1999; Reiss, Peterson, Gursky, & McNally, 
1986; Schmidt & Mallott, 2006; Taylor, 1996; Wilson & 
Hayward, 2006). Importantly, it has been shown that AS is 
more than a mere correlate of psychopathology by predict­
ing the incidence of Diagnostic and Statistical Manual o f  
Mental Disorders, fourth edition (American Psychiatric 
Association, 1994) Axis I pathology, particularly panic 
symptoms and panic disorder in adolescents and adults 
(Plehn & Peterson, 2002; Schmidt et al., 2010; Schmidt, 
Zvolensky, & Maner, 2006). Currently, AS is seen as a
prominent cognitive risk factor in the pathogenesis of anxi­
ety (Schmidt, 1999).
The important role of AS in anxiety pathology becomes 
evident by comparing AS scores between patients with dif­
ferent clinical diagnosis or between persons with versus 
without diagnosis. In a recent meta-analysis, Olatunji and 
Wolitzky-Taylor (2009) reported greater AS among anxiety 
and mood disorder patients compared with nonclinical con­
trols, d  = 1.61 and = 0.71, respectively. Elevated levels of 
AS can be found for patients with panic disorder and agora­
phobia (Reiss et al., 1986), social phobia and specific 
phobia ( Sandin, Chorot, & McNally, 1996), obsessive com­
pulsive disorder (Calamari, Rector, Woodard, Cohen, & 
Chik, 2008), posttraumatic stress disorder (Leen-Feldner,
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Feldner, Reardon, Babson, & Dixon, 2008), and depression 
(Otto, Pollack, Fava, Uccello, & Rosenbaum, 1995). 
Compared with patients with other anxiety disorders or 
nonclinical controls, patients with panic disorder and/or 
agoraphobia usually have the highest AS scores (Deacon & 
Abramowitz, 2006; Taylor et al., 2007).
AS is not a unitary construct as originally proposed by 
Reiss (1991). Actually, numerous studies suggest that AS is 
best conceptualized as a hierarchical construct that is com­
posed of three lower order dimensions: Somatic Concerns, 
Social Concerns, and Cognitive Concerns (Taylor et al., 
2007; Zinbarg, Barlow, & Brown, 1997). These lower order 
dimensions seem to be of different impact in the develop­
ment and maintenance of anxiety problems as each dimension 
is associated with thematically related anxiety psychopa­
thology. For example, the factor Somatic Concerns is most 
strongly correlated with phenomena pertaining to panic and 
agoraphobia. Zinbarg, Brown, Barlow, and Rapee (2001) 
found that this factor is the only one of the three lower order 
factors that contributes to relations with fear responses to 
laboratory panic challenges. Moreover, measures of this 
factor correlate substantially withbody vigilance (Zvolensky 
& Forsyth, 2002) and a diagnosis of panic disorder and/or 
agoraphobia (Taylor et al., 2007). In contrast, the AS factor 
Social Concerns is substantially correlated with trait mea­
sures covering interpersonal behavior such as fear of nega­
tive evaluation and extraversión (Kemper, Ziegler, & 
Taylor, 2009) and a diagnosis of social phobia (Taylor et al., 
2007). Finally, the Cognitive Concerns factor shows mod­
erate to high correlations with measures of depression 
(Armstrong et al., 2006) and seems to be a relatively non­
specific measure of general distress (Taylor, Koch, Woody, 
& McLean, 1996).
The majority of studies conducted during the past 
25 years focus on the latent dimensionality of the AS con­
struct. These studies suggest that AS is a multidimensional 
and hierarchically organized construct with one general fac­
tor and three to four lower order factors which seem differen­
tially related to various forms of psychopathology. Besides 
this dimensional approach some researchers have applied 
other approaches in AS structural research to test a conjec­
ture first formulated by Taylor (1999) and later adopted and 
elaborated by Bernstein et al. (2007). These authors suggest 
that the latent structure of AS might not be dimensional but 
categorical or a mixture thereof and that only one of two 
postulated latent classes is uniquely associated with vulner­
ability for anxiety psychopathology. If this conjecture was 
empirically supported, its impact on our understanding of 
the role AS plays in the etiology of psychopathology would 
be strong. Bernstein and colleagues applied elaborate statis­
tical methods, for example, coherent cut kinetic taxometric 
methods (Waller & Meehl, 1998), a mixture of coherent cut 
kinetic taxometric and factor analytic methods, and factor 
mixture modeling (Muthén, 2008), to support their claim.
They were able to present findings from demographically 
and geographically diverse samples (for an overview, see 
Bernstein et al., 2010) corroborating their claim that “AS 
has a taxonic (two-class) latent structure, and that each class 
has a unique multidimensional factor structure” (Bernstein 
et al., 2010, p. 527). However, their claim concerning the 
categorical two-class structure is not uncontroversial. Their 
position is currently challenged by several researchers who 
could not find evidence for the two postulated substantive 
AS classes (Asmundson, Weeks, Carleton, Thibodeau, & 
Fetzner, 2011; Broman-Fulks et al., 2008; Broman-Fulks 
et al., 2010; Kemper, 2010). This issue is far from being 
settled as both positions seem supported by comprehensive 
evidence.
However, measures of the construct that were developed 
in the past (for an overview see Peterson & Plehn, 1999) 
rest on the assumption that the latent AS structure is dimen­
sional. Between 1986 and 2009, the Anxiety Sensitivity 
Index (ASI; Reiss et al., 1986) was the most frequently used 
measure of the construct (Kemper, 2010). Because of criti­
cism pertaining to aspects of its psychometric quality the 
ASI was revised twice. In 1998, Taylor and Cox proposed 
the Anxiety Sensitivity Index-Revised (ASI-R) as a broad 
measure of AS and its lower order dimensions. Because of 
its unstable factor structure (cf. Taylor et al., 2007) another 
revision took place. The most recent version, the Anxiety 
Sensitivity Index-3 (ASI-3) was proposed by Taylor and 
colleagues in 2007.
The 18-item ASI-3 assumes a hierarchical three-factor 
structure of the construct and yields measures of Somatic 
Concerns (e.g., “It scares me when my heart beats rapidly”), 
Social Concerns (e.g., “It is important for me not to appear 
nervous”), and Cognitive Concerns (e.g., “When I cannot 
keep my mind on a task, I worry that I might be going 
crazy”) for the first-order level, and Global AS for the 
second-order level. Some studies confirming the psychomet­
ric quality have been conducted so far using nonclinical sam­
ples. The three-factor hierarchic structure of the ASI-3 
was confirmed in several geographically diverse North 
American samples (Taylor et al., 2007), thereby corroborat­
ing the consensus reached among AS researchers on the 
structure of the ASI (Zinbarg et al., 1997). Invariance of the 
internal structure between different countries was supported 
(Kemper et al., 2009). Further evidence concerning the con­
struct validity of the ASI-3 was obtained in these studies as 
well as in others (e.g., Osman et al., 2010). Notably, the 
ASI-3 was found to be superior to its predecessors ASI and 
ASI-R. Taylor et al. (2007) demonstrated that the ASI-3 
measures the construct more precisely— the ASI-3 has a 
higher reliability and construct validity than the ASI. In 
contrast to the ASI-R, the internal structure of the ASI-3 is 
stable across diverse samples. According to these results, 
the ASI-3 may be considered a reliable and valid measure 
of the most robust dimensions of the AS construct.
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In the upcoming years, the ASI-3 might well become the 
standard tool of AS assessment. Thus, further research on 
its psychometric quality is necessary. The construct validity 
of the ASI-3 was already demonstrated in several nonclini- 
cal samples (Kemper et al., 2009; Osman et al., 2010). 
However, the question whether the ASI-3 is a useful assess­
ment tool in clinical psychology research and a feasible 
screening instrument in applied settings has been addressed 
only once so far. In their large psychometric study of the 
ASI-3, Taylor et al. (2007) also analyzed a subsample of 
patients. These authors obtained first evidence for the con­
struct validity of the ASI-3 in a clinical context by compar­
ing groups differing in primary diagnosis on ASI-3 subscale 
scores (criterion-related validity). To further advance 
knowledge on the usefulness of the ASI-3 for clinical 
research and assessment, we addressed different aspects of 
construct validity. Construct validity of the ASI-3 was 
assessed in two samples of patients with anxiety or mood 
disorders by (a) testing the three-factor hierarchical struc­
ture proposed by Taylor et al. (2007; factorial validity), 
( b) examining relations of ASI-3 scores with psychopathology- 
related constructs (convergent and discriminant validity), 
and ( c) comparing ASI-3 scores of patients with different 
clinical diagnoses (criterion-related validity; cf. Taylor 
et al., 2007).
Four sets of theoretical expectations pertaining to the 
four scales yielded by the ASI-3, Somatic, Social, Cognitive 
Concerns, and Global AS, guided the validation process.
(1) The ASI-3 measure of Global AS (GAS) should differ­
entiate between patients with anxiety disorder and patients 
with nonanxiety disorders since patients with anxiety disor­
ders have elevated levels of AS compared with other 
patients or persons without a clinical diagnosis (Olatunji & 
Wolitzky-Taylor, 2009).
Particularly, patients with panic disorder fear anxiety- 
related sensations because of their assumed aversive 
somatic consequences, for example, heart attack. Thus
(2) the Somatic Concerns subscale of the ASI-3 (SOM) 
should allow for a differentiation of patients with panic dis­
order and/or agoraphobia and patients with nonanxiety dis­
orders or other anxiety disorders (Taylor et al., 2007). 
Moreover, substantial correlations of the SOM subscale 
w ith measures of body vigilance and symptom burden 
should be observable in clinical samples as ( a) high AS per­
sons indicate a higher vigilance for somatic symptoms in 
self-reports (Zvolensky & Forsyth, 2002) and (b) a higher 
interoceptive accuracy concerning diverse somatic symp­
toms and processes compared with persons with low AS 
(Richards & Bertram, 2000).
The Social Concerns subscale of the ASI-3 (SOC) cap­
tures concerns and fear of social consequences of publicly 
observable anxiety reactions, for example, ridicule. Persons 
who experience problems in their interpersonal relationships, 
for example people who are shy, insecure, introverted, or
socially avoidant, may be particularly prone to the fear that 
their anxiety symptoms could be observed and evaluated by 
others in a negative way. Thus, (3) substantial correlations 
should be obtained between SOC and measures of interper­
sonal problems, fear of negative evaluation, or social pho­
bia (cf. Kemper et al., 2009; Naragon-Gainey, 2010).
The Cognitive Concerns subscale (COG) measures 
symptoms of anxiety that could lead to catastrophic cogni­
tive consequences: “Anxiety disorders have been found to 
be associated with particular forms of cognitive concerns” 
(Taylor et al., 2007, p. 185). For example, panic disorder 
seems to be associated with strong fears of catastrophic 
consequences (e.g., loss of control) which might arise from 
cognitive phenomena such as derealization. Generalized 
anxiety disorder (GAD) was found to be associated with the 
harmful effects of uncontrollable worry ( cf. Taylor et al., 
2007). Patients with depressive episode seem particularly 
prone to another form of cognitive concerns— rumination 
(Nolen-Hoeksema, 2000). Taken together, these results 
suggest that many anxiety and mood disorders involve dif­
ferent forms of cognitive concerns. Findings from the AS 
literature corroborate this suggestion by reporting substan­
tial correlations between AS Cognitive Concerns and mea­
sures of anxiety or mood disorders or elevated subscale 
scores of these diagnostic groups (Deacon & Abramowitz, 
2006; Naragon-Gainey, 2010; Otto et al., 1995; Rector, 
Szacun-Shimizu, & Leybman, 2007; Taylor et al., 2007). 
Thus ( 4) we expected to find substantial differences between 
patients diagnosed with an anxiety or mood disorder com­
pared with patients without such a diagnosis (nonanxiety 
nonmood disorder). Moreover, we expected substantial cor­
relations between COG and measures of depression symp­
toms (Naragon-Gainey, 2010).
Method
Participants
Two clinical samples were used in the following analyses. 
Sample 1 consisted of 514 patients receiving cognitive- 
behavioral or psychodynamic treatment at a psychothera­
peutic inpatient unit in Germany (cf. Watzke et al., 2010). 
Patients who fulfilled the criteria for at least one mental dis­
order according to the International Statistical Classification 
of Diseases and Related Health Problems 10th Revision 
(ICD-10) Chapter V (World Health Organization, 1992) 
with a primary diagnosis of neurotic, stress-related, and 
somatoform disorders (F41-49) or mood disorders (F30-39) 
were recruited. These clinical diagnoses were chosen for 
the present investigation as these patients are affected by 
elevated AS scores (Olatunji & Wolitzky-Taylor, 2009). 
Sample 1 did not contain persons with diagnoses F I0-19 as 
persons with a primary diagnosis related to substance abuse 
are not routinely treated at the clinic. Sample 1 was 73%
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female, with a mean age of 47 years (SD = 10 years). In 
terms of the International Standard Classification of 
Education, 44% had completed lower secondary education 
and 38% upper secondary education. A total of 21% were 
single, 46% were married, and the remaining were sepa­
rated, widowed, or divorced. In all, 55% received some 
form of psychopharmacological treatment ( antidepressants, 
anxiolytics, neuroleptics, etc.). All diagnoses were assessed 
clinically and were based on ICD-10 criteria (for details on 
the diagnostic process, see below). Primary diagnoses in 
terms of severity or relevance to treatment1 were the fol­
lowing: depressive disorders (F33.0-F33.9, n = 248), 
adjustment disorders (F43.2, n = 118), agoraphobia and 
panic disorder with/or without agoraphobia (F40.0, F41.0, 
n = 38), mixed anxiety-depression (F41.2, n = 17), somato­
form disorders (F45.1/3, n = 16), dysthymia (F34.1, n = 14), 
posttraumatic stress disorder (F43.1, n = 13), complex 
chronic pain disorder (F45.4, n = 13), generalized anxiety 
disorder (F41.1, n = 11), other specified neurotic disorders 
(F48.8, n = 9), social phobia (F40.1, n = 5), obsessive- 
compulsive disorder (F42.-, n = 6), other anxiety disorders 
(F41.8-9, n = 2), dissociative disorders (F44.-, n = 3), and 
bipolar disorder (F31.-, n = 1).
Sample 2 was composed of 75 outpatients of various 
psychotherapists in the Rhine-Main Metropolitan Region of 
Germany receiving cognitive-behavioral treatment at the 
time of assessment. In total, 84% of the sample was female. 
Mean age of patients was 39 years (SD = 12 years). In all, 
57% had completed lower secondary education and 43% 
upper secondary education. Almost half of the sample 
(49%) was married, 37% were single, and the remaining 
were separated or divorced. Inclusion criteria were the same 
as in Sample 1. Diagnoses were assessed clinically and 
were based on ICD-10 criteria. Primary diagnoses in 
terms of severity were as follows: depressive disorders 
(F33.0-F33.9, n = 35), panic disorder with/or without ago­
raphobia (F40.0, F41.0, n = 11), adjustment disorders 
(F43.2, n = 12), anxiety disorder-unspecified (F41.9, n = 9), 
posttraumatic stress disorder (F43.1, n = 2), generalized 
anxiety disorder (F41.1, n = 2), mixed anxiety depression 
(F41.2, n = 2), and specific phobia (F40.2, n = 2). To achieve 
more robust means, Sample 1 and Sample 2 were merged 
for further analyses.
Measures and Procedure
Sample 1 was recruited at the in-patient unit described 
above. The clinic is part of routine mental health care in 
Germany. About 90% of patients are referred to the clinic 
by a physician who works for the German pension or health 
insurance. The physician usually conducts unstructured 
clinical interviews, assigns a preliminary diagnosis, and 
forwards the diagnostic information to the clinic. The diag­
nostic process in the clinic is a systematic and standardized
multistage procedure (cf. Watzke et al., 2010). In the admis­
sion phase, patients complete a comprehensive question­
naire containing psychometric measures (outlined below) 
and questions concerning the patient’s sociodemographics, 
medical and psychological condition, level of functioning, 
and well-being in various domains. Afterwards, the patient 
is assigned to a responsible psychotherapist who is an expe­
rienced diagnostician— a psychiatrist or psychologist who 
either completed a multiyear postgraduate professional 
training or is currently in training and works under supervi­
sion. He rediagnoses the patient based on ICD-10 symptom 
checklists (e.g., Hiller, Zaudig, & Mombour, 1996), data 
from psychometric assessment, and diagnostic information 
forwarded by the referring physician. Up to five diagnoses 
are assigned starting with the most severe to the least severe. 
After 3 weeks of therapy, initial diagnoses are reviewed for 
accuracy in a staff meeting by a multiprofessional team of 
experienced diagnosticians including the director of the 
unit and the responsible psychotherapist among others. 
Confirmation or modification of initial diagnosis is based 
on a consensus decision among experts. By this systematic 
and standardized multistage diagnostic process— involving 
different experienced diagnosticians who integrate multiple 
data sources such as clinical interviews and psychometric 
measurement— a reliable diagnosis is ensured (cf. Watzke 
et al„ 2010).
Psychometric assessment included several measures.2 
The German adaptation (Kemper et al., 2009) of the ASI-3 
(Taylor et al., 2007) was administered. To assess interper­
sonal behavior, the German adaptation (Horowitz, StrauB, 
& Kordy, 2000) of the Inventory of Interpersonal Problems 
(IIP, Horowitz, Rosenberg, Baer, Ureno, & Villasenor, 
1988) was used. The IIP comprises the two orthogonal 
dimensions: affiliation and dominance. The two-dimensional 
space is further divided into eight broad categories of 
interpersonal behavior (octants): PA = Domineering, BC = 
Vindictive, DE = Cold, FG = Socially Inhibited, HI = 
Submissive, JK = Exploitable, LM = Overly Nurturant, 
NO = Intrusive (.36 < a < .64). Depression symptoms were 
measured with a German short form ( ADS-K; Hautzinger 
& Bailer, 1993; a = .90) of the Center of Epidemiologic 
Studies Depression Scale (CES-D; Radloff, 1977). The 
German trait version (Laux, Glanzmann, Schaffner, & 
Spielberger, 1981; a = .90) of the State-Trait Anxiety 
Inventory (STAI; Spielberger, Gorsuch, & Lushene, 
1970) was used to assess interindividual differences in 
anxiety. Symptom burden was assessed with the SCL-14 
(Harfst et al., 2002; a = .87), a brief German version of 
the Symptom Check L ist-90 -R  (Derogatis, Rickels, & 
Rock, 1976). To measure bodily discomfort in four differ­
ent domains (exhaustion, rheumatism, abdominal pain, 
and heart complaints) the Giessen Subjective Complaints 
List (GBB-24; Brâhler & Scheer, 1995; a = .93) was 
administered.
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Participants in Sample 2 received most of the psycho­
metric measures administered in Sample 1. They completed 
the ASI-3, CES-D, and the STAI. Additionally, they were 
asked to fill out a German adaptation (Vormbrock & 
Neuser, 1983; a = .83) of the Fear of Negative Evaluation 
Scale (FNE, Watson & Friend, 1969) and the Body 
Vigilance Scale (BVS; Schmidt, Lerew, & Trakowski, 
1997; a = .83). The FNE measures the disposition to fear 
potential negative evaluation by others. Fear of negative 
evaluation is thought to be a core cognitive factor of social 
anxiety and social phobia (e.g., Clark & Wells, 1995). Body 
vigilance, as assessed by the BVS, denotes consciously 
attending to internal bodily sensations and perturbations. 
This normally adaptive process has been found to be exag­
gerated in patient samples (Schmidt et al., 1997). As in 
Sample 1, participants filled out the questionnaire before 
the commencement of treatment.
The study protocol described above was approved by the 
local human ethics committee. All patients who participated 
in the present research received a complete description of 
the study and provided written informed consent prior to 
data collection.
Statistical Analysis
Data analysis was conducted in four steps: (1) At first, 
descriptive statistics for the general scale and three sub­
scale scores of the ASI-3 as well as reliability coefficients 
(Cronbach’s alpha) were computed and evaluated accord­
ing to Nunnally and Bernstein (1994; a > .70 = acceptable, 
a > .80 = good). Afterward, several aspects of construct 
validity of the ASI-3 were tested.
(2) Factorial validity was investigated using a structural 
equation modeling approach. The three-factor hierarchical 
model confirmed by Taylor et al. (2007) for the ASI-3 and 
by Kemper et al. (2009) for its German adaptation in essen­
tially nonclinical samples was fitted to the combined clini­
cal sample using robust maximum likelihood estimation in 
MPlus 6. Model fit assessment was based on fit indices rec­
ommended by Beauducel and Wittmann (2005). These 
authors favor the SRMR (standardized root mean square 
residual) and the RMSEA (root mean square error of 
approximation) particularly with regard to latent trait mod­
els. Assessment of model fit was based on criteria proposed 
by Hu and Bentler (1999).
(3) Group differences in ASI-3 scores of patients diag­
nosed with specific mental disorders were tested according 
to theoretical expectations outlined above. Because of the 
low frequency of some disorders in the merged sample, we 
formed four groups based on primary ICD-10 diagnosis— 
panic disorder/agoraphobia (panic disorder with or without 
agoraphobia), other anxiety disorder (social phobia, GAD, 
and PTSD), mood disorder (depressive episode and dysthy- 
mia), nonanxiety or nonmood disorder (somatoform and
adjustment disorder)—to test our theoretical expectations. 
Only diagnoses with n > 5 were classified into these groups. 
Diagnoses that could not be classified unambiguously were 
excluded from the analysis, for example, mixed anxiety- 
depression (F43.1).
To consider comorbidity and the potential role of the 
secondary diagnosis, we performed analyses of variance 
(ANOVA) with the primary diagnosis (panic disorder/ 
agoraphobia, other anxiety disorder, mood disorder, non­
anxiety or nonmood disorder), the secondary diagnosis (no 
secondary diagnosis, panic disorder/agoraphobia, other 
anxiety disorder, mood disorder, nonanxiety or nonmood 
disorder, substance use disorder), and the primary diagnosis 
by secondary diagnosis interaction as predictors, and the 
relevant ASI-3 subscales as criteria. The interaction was 
included to reveal any contribution of specific combina­
tions of primary and secondary diagnoses to the prediction. 
Because of the imbalanced design— caused by unequal cell 
sizes— there are different choices concerning the type of 
sums of squares for the ANOVAs. We used so-called Type 
I sums of squares, in which the contribution of the predic­
tors in a model are tested sequentially. Because of its impor­
tance, the primary diagnosis was entered before the 
secondary diagnosis; the interaction was entered last. In this 
way it is possible to answer the question whether the sec­
ondary diagnosis adds in any way to the prediction of the 
ASI scores, over and above the prediction already possible 
by the primary diagnosis. Subsequently, follow-up tests 
(a = .05) were conducted and effect sizes (Hedges’ [1981] g) 
were calculated.
(4) Correlational analyses were conducted to further 
examine theoretical expectations concerning convergent 
and discriminant validity of the ASI-3 scales. To demon­
strate the differential validity of subscales, correlation 
coefficients between ASI-3 subscales and psychopathology- 
related measures were also tested for substantial differences 
with methods proposed for the comparison of correlated 
correlation coefficients (Meng, Rosenthal, & Rubin, 1992; 
Steiger, 1980).
Results
Descriptive Statistics and Reliability
Descriptive statistics and reliability coefficients are pre­
sented in Table 1. In Sample 1, ASI-3 total scores ranged 
from 0 to 72, in Sample 2 from 5 to 72, respectively. Scores 
for the Social Concerns subscale ranged from 0 to 24 in 
Sample 1 and from 1 to 24 in Sample 2, respectively. Scores 
for Cognitive Concerns and Somatic Concerns ranged from 
0 to 24 in Sample 1 and Sample 2 as well. Both samples 
showed nearly exactly the same means and standard devia­
tions. A multivariate analysis o f variance of the ASI-3 
scales did not yield any significant differences between
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Table I. Descriptive Statistics and Reliability Coefficients for 
Anxiety Sensitivity Index-3 Subscales
Sample 1 (N = 514) Sample 2 (N = 75)
M SD a M SD a
GAS 33.05 15.81 .92 33.81 15.84 .92
SOM 9.74 6.20 .88 9.69 6.61 .89
SOC 12.09 5.93 .83 13.05 6.19 .85
COG 1 1.22 6.39 .88 1 1.07 6.36 .89
Note. GAS = Global Anxiety Sensitivity; SOM = Somatic Concerns; 
SO C  = Social Concerns; C O G  = Cognitive Concerns.
samples, W ilks’s X = .99, F(3, 585) = 1.79, p  > .05. 
Reliability coefficients for the ASI-3 scales (.85 < a < .92) 
may be considered good according to Nunnally and 
Bernstein (1994).
Factorial Validity
The three-factor hierarchical model of the ASI-3 is depicted 
in Figure 1. No exact model fit was achieved = 583.0, 
d f=  133, p  < .001, SRMR = .07, RMSEA = .07 [.07-.08], 
CFI = .90). Modification indices (Mis) were inspected to 
identify potential sources of model misfit. Inspection of the 
M is pointed to several residual correlations within the 
Cognitive Concerns subscale. The three highest Mis were 
found for the residuals of Item 2 (“When I cannot keep my 
mind on a task, I worry that I might be going crazy”) and 
Item 5 (“It scares me when I am unable to keep my mind 
on a task”), residual correlation r  = .39; Items 2 and 14 
(“When my thoughts seem to speed up, I worry that I might 
be going crazy”), residual correlation r  = .24; and Item 16 
(“When I have trouble thinking clearly, I worry that there is 
something wrong with me”) and Item 18 (“When my mind 
goes blank, I worry that there is something terribly wrong 
with me”), residual correlation r  = .25. Apparently, these 
correlated residuals are not because of conceptual reasons— 
misspecification of the model—but because of technical 
aspects of the ASI-3, that is, an overlap in wording of some 
items. Thus, we included these residual correlations in the 
model, thereby yielding an acceptable fit for the three- 
factor hierarchical model of the ASI-3 (x2 = 439.9, df=  130, 
p  < .001, SRMR = .05, RMSEA = .06 [.05-.07], CFI = .94). 
All items had substantial loadings on their respective fac­
tors (.49 < X < .84) and lower order factors had high load­
ings on the higher order AS factor, SOM X = .69, SOC 
X = .85, and COG X = .96, supporting a global AS construct.
Convergent, Discriminant, 
and Criterion-Related Validity
Results are presented in order of the four theoretical expec­
tations described above:
1. Group difference in GAS w ith respect to the 
primary diagnosis were substantial and highly sig­
nificant, F(3, 461) = 11.16,/? < .001. Neither the 
secondary diagnosis, F(5,461) = 0.93,p  > .05, nor 
the combination of primary and secondary diag­
nosis, F(14, 461) = 1.09, p  > .05, yielded unique 
contributions to this differentiation. Follow-up 
tests showed that patients diagnosed with anxiety 
disorders (N  = 78; M =  40.68; SD = 15.91) had 
significantly higher scores compared with those 
with nonanxiety disorders (N  = 406; M  = 31.53; 
SD=  15.58; i[482] =4.74,/) < .001, Hedges’ g  = .58).
2. There was also a significant difference in SOM 
scores ofpatients,F( 3 ,461)=  15.12,/) <.001. Main 
effect of secondary diagnosis, F( 5, 461) = 0.66, 
p  > .05, and the interaction were not significant, 
F(14, 461) = 1.21,/) > .05. Patients diagnosed 
with panic disorder and/or agoraphobia (N  = 45; 
M  = 14.84; SD  = 6.50) had significantly higher 
scores than those diagnosed with other anxiety 
disorders (N  = 33; M  = 11.12; SD  = 7.35;/) < .05, 
Hedges’ g  = .52) and those with nonanxiety dis­
orders (N  = 406; M  = 8.83; SD  = 5.83;p  < .001, 
Hedges’ g  = .95). The difference between patients 
with other anxiety disorders and those with non­
anxiety disorders was not significant (p > .05, 
Hedges’ g  = .33). Correlations between ASI-3 
scores and different psychopathology-related 
measures are depicted in Table 2. As expected, 
SOM scores were substantively associated with 
measures of self-reported body vigilance (r = .56, 
p  < .01), and symptom burden (GBB, r  = .37, 
p  < .01; SCL, r = .42, p  < .01). Moreover, cor­
relations with psychopathology-related measures 
differed across ASI-3 subscales supporting their 
differential validity. For example, correlations 
between BVS and ASI-3 subscales were sub­
stantially higher for SOM than for COG (t = 2.2, 
p  < .05) and SOC (t = 2 .8 ,/) < .01). Some cor­
relations between ASI-3 subscales and measures 
of symptom burden were also significantly differ­
ent, for example, correlations of COG versus SOC 
with psychopathology-related measures were sub­
stantially higher for GBB (t = -4 .5 , p  < .01) and 
for SCL-14 (t = -2 .8 ,/) < .01). However, criterion 
correlations of SOM were not higher compared 
with SOC and COG. Thus, theoretical expecta­
tions were not met in the case of symptom burden 
as strongest correlations were not observed for SOM.
3. In line with theoretical expectations from the AS 
literature, SOC scores were positively associated 
with fear of negative evaluation (r = .66, p  < .01) 
and theoretically related IIP octants. As expected, 
the highest correlation of ASI-3 subscales with
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Figure I. Model of the Anxiety Sensitivity Index-3 in the combined clinical sample
Note. SOC = Social Concerns; COG = Cognitive Concerns subscale; SOM = Somatic Concerns; AS = Anxiety Sensitivity.
Table 2. Convergent and Discriminant Validity Coefficients of 
Anxiety Sensitivity Index-3 Subscales
BVSa CES-Db STAIb FNEa GBB-24b SCL-14b
GAS .47 .34 .61 .64 .42 .53
SOM .56 .21 .41 .38 .37 .42
SOC .26 .29 .55 .66 .28 .43
COG .33 .36 .59 .57 .42 .51
Note. GAS = Global Anxiety Sensitivity; SOM = Somatic Concerns;
SOC = Social Concerns; C O G  = Cognitive Concerns; BVS = Body 
Vigilance Scale; CES-D = Center of Epidemiologic Studies Depression 
Scale; STAI = State-Trait Anxiety Inventory; FNE = Fear of Negative 
Evaluation Scale; GBB-24 = Giessen Subjective Complaints List; SCL-14 = 
Symptom Check List. All correlations are significant with p < .01 
except for SO C  and BVS (p < .05).
a.N = 75.
b.N = 512-589.
FNE was observed for SOC. The correlation of 
SOC with FNE was substantially higher than the 
correlation of SOM with FNE (t = -2 .8 , p  < .01). 
However, validity coefficients of SOC and COG 
did not differ. In Figure 2, differential associations 
of ASI-3 subscales and IIP octants are presented. 
As expected, SOC scores were positively associ­
ated with Social Inhibition (FG, r = .29, p  < .01) 
and Submissiveness (HI, r= A4,p  < .05), and nega­
tively associated with Domineering (PA, r  = -.28 , 
p  < .01) and Intrusiveness (NO, r  = -.18,/> < .01).
Cognitive Concerns scores also showed some 
minor but significant correlations with IIP mea­
sures (highest: PA, r  = ~.\A,p  < .01). There were 
no significant associations of SOM scores and IIP 
scales.
4. Concerning COG scores, groups substantially 
differed. A main effect of primary diagnosis,
F(3, 461) = 5.46, p  < .01, but not for secondary 
diagnosis, F(5,461) = 0.95,p  > .05, was observed. 
The interaction was not significant, F( 14,461) = 1.16 
p  > .05. Confirming the theoretical expectation 
derived from the AS literature, patients with a 
diagnosis of an anxiety or mood disorder (N = 342;
M  = 11.99; SD = 6.35) had higher COG scores 
compared with those not diagnosed with an 
anxiety or mood disorder (N = 142; M  = 9.57;
SD = 6.40; i[482] = 3.81, p  < .001; Hedges’ 
g  = .38). COG was also correlated with depression 
symptoms as expected (r= .36,p  < .01). Moreover, 
this correlation with the CES-D was substantially 
higher for COG compared with SOM (t = -4 .5 , 
p  < .01) and SOC (t = -2 .5 , p  < .05) supporting 
differential validity of the ASI-3 subscales.
Besides statistical associations pertaining to the theo­
retical expectations reported above, further results concern­
ing the GAS score seem noteworthy. GAS correlated 
substantially with diverse measures of psychopathology- 
related constructs. Strong correlations were observed with
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Figure 2. Correlations between Anxiety Sensitivity Index-3 
subscales and Inventory of Interpersonal Problems (IIP) octants 
Note. SOC = Social Concerns; COG = Cognitive Concerns; 
SOM = Somatic Concerns; PA = Domineering; BC = Vindictive; 
DE = Cold; FG = Socially Inhibited; HI = Submissive; J K  = 
Exploitable; LM = Overly Nurturant; NO = Intrusive.
FNE, STAI, SCL-14, and BYS. Correlations of medium 
size were observed with CES-D and GBB-24.
Discussion
As indicated by prior research, the recently developed 
ASI-3 seems a promising candidate for a standard assess­
ment tool in AS research. However, results concerning the 
construct validity of the ASI-3 in clinical samples are still 
sparse. In the study presented here, we sought to find com­
prehensive evidence on the usefulness of the ASI-3 in 
clinical psychology research and applied settings. To this 
purpose, different aspects of the construct validity of the 
ASI-3 were tested in two clinical samples. The three-factorial 
structure of the ASI-3 found in nonclinical student samples 
was corroborated in a sample of patients with primary diag­
nosis of anxiety or mood disorder. The subscale scores of 
the measure showed different patterns of statistical relations 
with clinical diagnosis of mental disorders, interpersonal 
functioning, body vigilance, and symptom burden which 
are consistent with AS literature. These results will be 
addressed in further detail below.
Because the structure of the ASI-3 had been established 
in previous studies, we applied a confirmatory approach to 
test the factorial validity of the ASI-3. The three-factor 
model proposed by Taylor et al. (2007) yielded an accept­
able fit to the data. All items had high and substantial load­
ings on three substantially correlated factors which measure 
somatic, social, and cognitive concerns about anxiety-related 
sensations. Correlations among factors were high and
consistent with previous AS research (cf. Taylor et al., 
2007, Study 2) thereby supporting a global AS construct. 
An objection some researchers might have concerning 
model fit relates to residual correlations of items within the 
Cognitive Concerns factor. However, these residual corre­
lations were because of an overlap in item wording rather 
than conceptual reasons. They do not contradict the facto­
rial validity o f the ASI-3. Since residual correlations were 
not observed before, assuming sample specific influences 
seems reasonable in this case. Our results are in line with 
results from the initial validation study of Taylor et al. 
(2007) and a validation study o f the German adaptation 
(Kemper et al., 2009). Results presented by these authors 
support a three-factor hierarchic structure for nonclinical 
samples from North America, Spain, Mexico, France, the 
Netherlands, and Germany. According to our results, the 
three-factor hierarchic structure o f the ASI-3 seems to apply 
to clinical samples as well.
Further evidence supporting the construct validity of the 
ASI-3 in clinical samples was gathered. We examined mean 
differences in ASI-3 scores between patients differing in 
clinical diagnosis and correlations between ASI-3 scales 
and other psychopathology-related constructs. Our pattern 
o f results was highly consistent with findings from AS 
research. Global AS scores of patients allowed for a differ­
entiation of patients with and without anxiety disorder diag­
nosis (cf. Deacon & Abramowitz, 2006; Olatunji & 
Wolitzky-Taylor, 2009; Reiss et al., 1986). Furthermore, 
the Global AS score showed a pattern of relations to other 
constructs well known from the AS literature. Highest 
correlations were observed with measures of anxiety and, 
lower but still substantial correlations emerged with mea­
sures of body vigilance, symptom burden, and interpersonal 
functioning (cf. Armstrong et al., 2006; Deacon & 
Abramowitz, 2006; Naragon-Gainey, 2010; Zvolensky & 
Forsyth, 2002). For ASI-3 subscales, expectations derived 
from the AS literature were also met. The Somatic Concerns 
subscale allowed for the differentiation of patients with 
panic disorder and/or agoraphobia from patients with other 
anxiety disorders or nonanxiety disorders (cf. Reiss et al., 
1986; Taylor et al., 2007) and subscale scores correlated 
with measures o f body vigilance and symptom burden 
(cf. Asmundson, Frombach, & Hadjistavropoulos, 1998; 
Osman et al., 2010; Richards & Bertram, 2000; Zvolensky 
& Forsyth, 2002). For the Social Concerns subscale which 
captures the fear of publicly observable anxiety reactions, 
substantial correlations with fear o f negative evaluation and 
interpersonal behavior— IIP octants— emerged as expected. 
We found convergent correlations for octants measuring 
shy, insecure, introverted, or socially avoidant behavior and 
discriminant correlations for octants measuring outgo­
ing, assertive, or dominant behavior (cf. Cox, Borger, 
Taylor, Fuentes, & Ross, 1999; Deacon & Abramowitz, 
2006). Concerning ASI-3 Cognitive Concerns, theoretical
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expectations derived from the AS literature were met as 
well. As expected, scores of patients with versus without an 
anxiety or mood disorder differed substantially in Cognitive 
Concerns (cf. Taylor et al., 2007) and subscale scores were 
substantially related to depression symptoms ( cf. Naragon- 
Gainey, 2010; Osman et al., 2010; Otto et al., 1995).
Adding to the construct validity of the ASI-3 is the fact 
that different correlations with psychopathology-related 
constructs were found for ASI-3 subscales. For example, 
Somatic Concerns seems specifically related to vigilance 
for somatic symptoms. Correlation of this subscale with 
body vigilance was substantially higher compared with 
other ASI-3 subscales. Evidence for differential validity 
emerged with measures of symptom burden as well. But 
contrary to expectations, highest correlations were not 
observed with Somatic Concerns but with Cognitive 
Concerns. However, this unexpected finding may rather be 
due to an inappropriate expectation in the first place rather 
than a lack of validity of the Somatic Concerns subscale. 
Further evidence suggests differential validity of ASI-3 
subscales. Social Concerns seems specifically related to 
fear of negative evaluation and thematically relevant IIP 
octants. Concerning Cognitive Concerns, highest and sub­
stantially different correlations were observed with depres­
sion symptoms compared with correlations with other 
subscales.
Taken together, we gathered considerable evidence 
supporting the construct validity of the ASI-3 by replicat­
ing (a) the three-factor hierarchic structure proposed by 
Taylor et al. (2007), (b) statistical associations of the 
ASI-3 scales with different psychopathology-related con­
structs reported in previous AS research, and (c) differ­
ences in ASI-3 subscale scores of patients differing in 
primary clinical diagnosis while controlling for possible 
effects o f comorbidity.
A limiting factor of the present research was sample 
size. In future studies on the usefulness of the ASI-3 in 
clinical psychology research and practice, a larger sample 
size is preferable. In the research presented here, patients 
with certain disorders were undersampled, for example, 
patients with social phobia, generalized anxiety disorder, 
posttraumatic stress disorder, or hypochondriasis. Thus, 
differences in ASI-3 subscale scores for these groups of 
patients could not be tested. Furthermore, reference scores 
for patients with different anxiety or mood disorders are 
necessary for clinical assessment procedures. These scores 
should be sufficiently stable, that is, calculated from a 
large sample.
Due to these limitations, our study can only be seen as 
an important first step in testing the construct validity of 
the ASI-3 in clinical samples. To establish the ASI-3 as a 
useful and appropriate assessment tool in clinical psychol­
ogy research and practice, an extension of our work is 
highly encouraged.
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Notes
1. Relevance for treatment means that if  a medical condition (e.g., 
heart disease) and a mental disorder (e.g., GAD) co-occur, the 
mental disorder was considered as relevant to psychotherapeu­
tic treatment.
2. Reliability coefficients (Cronbach’s alpha) for measures used 
in the validation process could not be calculated in Sample 1. 
The clinic provided only a reduced data set without item-level 
data because o f  data privacy protection. Thus, we report alpha 
coefficients for each measure from the literature based on the 
initial validation samples o f  the measures.
References
American Psychiatric Association. (1994). Diagnostic and statis­
tical manual o f  mental disorders (4th ed). Washington, DC: 
Author.
Armstrong, K. A., Kliawaja, N. G., & Oei, T. P. S. (2006). Con­
firmatory factor analysis and psychometric properties o f  the 
Anxiety Sensitivity Index-Revised in clinical and normative 
populations. European Journal o f  Psychological Assessment, 
22, 116-125. doi: 10.1027/1015-5759.22.2.116 
Asmundson, G. J., Frombach, I. K., & Hadjistavropoulos, H. D.
(1998). Anxiety sensitivity: Assessing factor structure and 
relationship to multidimensional aspects o f  pain in injured 
workers. Journal o f  Occupational Rehabilitation, 8, 223-234. 
doi: 10.1023/A: 10213 82624491 
Asmundson, G. J. G., W eeks, J. W., Carleton, R. N., 
Thibodeau, M. A., & Fetzner, M. G. (2011). R evisiting the 
latent structure o f  the anxiety sensitivity  construct: M ore 
evidence o f  dim ensionality. Journal o f  A nxiety  D isorders, 
25, 138-147. doi: 10.1016/j.janxdis.2010.08.013 
Beauducel, A., & Wittmann, W. W. (2005). Simulation study 
on fit indexes in CFA based on data with slightly distorted 
simple structure. Structural Equation Modeling, 12, 41-75. 
doi: 10.1207/s 15328007sem 12 01 3  
Bernstein, A., Stickle, T. R., Zvolensky, M. J., Taylor, S., 
Abramowitz, J., & Stewart, S. (2010). Dimensional, cat­
egorical, or dimensional-categories: Testing the latent struc­
ture o f  anxiety sensitivity among adults using factor-mixture 
modeling. Behavior Therapy, 41, 515-529. doi: 10.1016/ 
j.beth.2010.02.003 
Bernstein, A., Zvolensky, M. J., Norton, P. J., Schmidt, N. B., 
Taylor, S., Forsyth, J. P., . . . Cox, B. (2007). Taxometric 
and factor analytic models o f  anxiety sensitivity: Integrating 
approaches to latent structural research. Psychological Assess­
ment, 19, 74-87. doi: 10.1037/1040-3590.19.1.74
98 Assessment 19( 1)
Brahler, E., & Scheer, J. W. (1995). D er Giessener Beschwerde- 
bogen. Handbuch [Giessen Subjective Complaints List]. Bern, 
Switzerland: Huber.
Broman-Fulks, J. J., Deacon, B. J., Olatunji, B. O., Bondy, C. L., 
Abramowitz, J. S., & Tolin, D. F. (2010). Categorical or dimen­
sional: A  reanalysis o f  the Anxiety Sensitivity construct. Behav­
ior Therapy, 41, 154-171. doi:10.1016/j.beth.2009.02.005 
Broman-Fulks, J. J., Green, B. A., Berman, M. E., Olatunji, B. O., 
Arnau, R. C., Deacon, B. J., & Sawchuk, C. N. (2008). The 
latent structure o f  anxiety sensitivity—Revisited. Assessment, 
15, 188-203. doi: 10.1177/1073191107311284 
Calamari, J. E., Rector, N. A., Woodard, J. L., Cohen, R. J., & 
Chik, H. M. (2008). A nxiety sensitivity and obsessive- 
compulsive disorder. Assessment, 15, 351-363. doi: 10.1177/ 
1073191107312611 
Clark, D. M., & Wells, A. (1995). A  cognitive model o f  social 
phobia. In R. G. Heimberg, M. R. Liebowitz, D. A. Hope, & 
F. R. Schneier (Eds.), Social phobia: diagnosis, assessment, 
and treatment (pp. 69-93). New York, NY: Guilford Press. 
Cox, B. J., Borger, S. C., Taylor, S., Fuentes, K., & Ross, L. M.
(1999). Anxiety sensitivity and the five-factor model o f  per­
sonality. Behaviour Research and Therapy, 37, 633-641. 
doi: 10.1016/S0005-7967(98)00174-0 
Deacon, B., & Abramowitz, J. (2006). Anxiety sensitivity and its 
dimensions across the anxiety disorders. Journal o f  Anxiety 
Disorders, 20, 837-857. doi:10.1016/j.janxdis.2006.01.003 
Derogatis, L. R., Rickels, K., & Rock, A. (1976). The SCL-90 and 
the MMPI: A  step in the validation o f a new self-report scale. 
British Journal o f  Psychiatry, 128, 280-290. doi: 10.1192/ 
b jp .128.3.280
Eifert, G. H„ Zvolensky, M. J., Sorrell, J. T„ Hopko, D. R„ & 
Lejuez, C. W. (1999). Predictors o f  self-reported anxiety and 
panic symptoms: A n evaluation o f anxiety sensitivity, suffoca­
tion fear, heart-focused anxiety, and breath-holding duration. 
Journal o f  Psychopathology and Behavioral Assessment, 21, 
293-305. doi: 10.1023/A: 1022116731279 
Harfst, T., Koch, U., Kurtz von Aschoff, C., Nutzinger, D. O., 
Riiddel, H., & Schulz, H. (2002). EntwicUung und Validier- 
ung einer Kurzform der Symptom Checklist-90-R [Develop­
ment and validation o f  a short version o f  the Symptom Check 
List-90 (SCL-90)\. DRV-Schriften, 3, 71-73.
Hautzinger, M., & Bailer, M. (1993). Allgemeine Depressions 
Skala [German version o f  the C enter o f  Epidemiologic Stud­
ies Depression Scale (CES-D)]. Weinlieim, Germany: Beltz 
Test.
Hedges, L. V. (1981). Distribution theory for Glass’s estimator 
o f  effect size and related estimators. Journal o f  Educational 
Statistics, 6, 107-128. doi: 10.2307/1164588 
Hiller, W., Zaudig, M., & Mombour, W. (1996). IDCL—International 
D iagnostic Checklists fo r  ICD -10 and D SM -IV  (Manual and 
32 checklists as part o f  the WHO ICD-10-Checklists package). 
Seattle, WA: Hogrefe and Huber.
Horo witz, L. M ., Rosenberg, S., Baer, B .,Ureno,G., & Villasenor, V. 
(1988). Inventory o f  interpersonal problems: Psychometric
properties and clinical applications. Journal o f  Consulting 
and Clinical Psychology, 56, 885-892. doi:10.1037/0022- 
006X.56.6.885
Horowitz, L. M., Strauß, B., & Kordy, H. (2000). Inventar zur 
Erfassung Interpersonaler Probleme IIP  [German version o f 
the Inventory o f  Interpersonal Problems (IIP-C)]. Göttingen, 
Germany: Beltz Test.
Hu, L. T., & Bentler, P. M. (1999). Cutoff criteria for fit indexes 
in covariance structure analysis: Conventional criteria ver­
sus new alternatives. Structural Equation Modeling, 6, 1-55. 
doi:10.1080/10705519909540118
Kemper, C. J. (2010). Das Persönlichkeitsmerkmal Angstsensitivität: 
Taxon oder Dimension ? Eine Analyse mit dem Mischverteilungs- 
Raschmodell [Trait Anxiety Sensitivity: Taxon or Dimension? A 
Mixed Rasch Model Analysis]. Hamburg, Germany: Dr. Kovac.
Kemper, C. J., Ziegler, M., & Taylor, S. (2009). Überprüfung der 
psychometrischen Qualität der deutschen Version des Angst- 
sensitivitätsindex-3 [Psychometric properties o f  the German 
version o f  the Anxiety Sensitivity Index 3]. Diagnostica, 55, 
223-233.
Laux, L., Glanzmann, P., Schaffner, P., & Spielberger, C. D. 
(1981). Das State-Trait-Angst Inventar (STAT). Theoretische 
Grundlagen und Handanweisung [German version o f the 
State-Trait Anxiety Inventory (STAI)]. Weinlieim, Germany: 
Beltz Test.
Leen-Feldner, E. W., Feldner, M. T., Reardon, L. E., Babson, K. A., 
& Dixon, L. (2008). Anxiety sensitivity and posttraumatic stress 
among traumatic event-exposed youth. Behaviour Research and 
Therapy, 46, 548-556. doi:10.1016/j.brat.2008.01.014
Meng, X.-L., Rosenthal, R., & Rubin, D. B. (1992). Comparing 
correlated correlation coefficients. Psychological Bulletin, 
111, 172-175. doi:10.1037/0033-2909.111.1.172
Muthen, B. (2008). Latent variable hybrids: Overview o f old and 
new models. In G. R. Hancock & K. M. Samuelsen (Eds.), 
Advances in latent variable mixture models (pp. 1-24). Charlotte, 
N C : Information Age.
Naragon-Gainey, K. (2010). Meta-analysis o f  the relations o f  
anxiety sensitivity to the depressive and anxiety disorders. 
Psychological Bulletin, 136, 128-150. doi:10.1037/a0018055
Nolen-Hoeksema, S. (2000). The role o f  rumination in depressive 
disorders and mixed anxiety/depressive symptoms. Journal 
o f  Abnormal Psychology, 109, 504-511. doi:10.1037/0021 - 
843X.109.3.504
Nunnally, J. C., & Bernstein, I. H. (1994). Psychometric theory. 
New York, NY: McGraw-Hill.
Olatunji, B. O., & Wolitzky-Taylor, K. B. (2009). Anxiety sensi­
tivity and the anxiety disorders: A  meta-analytic review and 
synthesis. Psychological Bulletin, 135, 974-999. doi: 10.1037/ 
aOO17428
Osman, A., Gutierrez, P. M., Smith, K., Fang, Q., Lozano, G., & 
Devine, A. (2010). The Anxiety Sensitivity Index-3: Analyses 
o f  dimensions, reliability estimates, and correlates in nonclini- 
cal samples. Journal o f  Personality Assessment, 92, 45-52. 
doi:10.1080/00223890903379332
Kemper et al. 99
Otto, M. W., Pollack, M. H., Fava, M., Uccello, R., & 
Rosenbaum, J. F. (1995). Elevated Anxiety Sensitivity Index 
scores in patients w ith m ajor depression: Correlates and 
changes with antidepressant treatment. Journal o f  Anxiety D is­
orders, 9, 117-123. doi:10.1016/0887-6185(94)00035-2 
Peterson, R. A., & Plehn, K. (1999). Measuring anxiety sensitiv­
ity. In S. Taylor (Ed.), Anxiety sensitivity: Theory, research, 
and treatment o f  the fea r  o f  anxiety (pp. 61-82). Mahwali, NJ: 
Lawrence Erlbaum.
Plehn, K., & Peterson, R. A. (2002). Anxiety sensitivity as a pre­
dictor o f  the development o f  panic symptoms, panic attacks, 
and panic disorder: A  prospective study. Journal o f  Anxiety 
Disorders, 16, 455-474. doi:10.1016/S0887-6185(02)00129-9 
Radio ff, L. S. (1977). TheCES-D Scale: Aself-report depression scale 
for research in the general population. Applied Psychological 
Measurement, 1, 385-401. doi: 10.1177/014662167700100306 
Rector, N. A., Szacun-Shimizu, K., & Leybman, M. (2007). Anxi­
ety sensitivity within the anxiety disorders: Disorder-specific 
senstivities and depression comorbidity. Behaviour Research 
and Therapy, 45, 1967-1975. doi:10.1016/j.brat.2006.09.017 
Reiss, S. (1991). Expectancy model o f  fear, anxiety, and panic. 
Clinical Psychology Review, 11, 141-153. doi:10.1016/0272- 
7358(91)90092-9 
Reiss, S., Peterson, R. A., Gursky, D. M., & McNally, R. J. 
(1986). Anxiety sensitivity, anxiety frequency and the predic­
tion o f  fearfulness. Behaviour Research and Therapy, 24, 1-8. 
doi:10.1016/0005-7967(86)90143-9 
Richards, J. C., & Bertram, S. (2000). Anxiety sensitivity, state and 
trait anxiety, and perception o f change in sympathetic nervous 
system arousal. Journal o f  Anxiety Disorders, 14, 413-427. 
doi: 10.1016/S0887-6185(00)00031-1 
Sandin, B., Chorot, P., & McNally, R. J. (1996). Validation o f the 
Spanish version o f  the Anxiety Sensitivity Index in a clini­
cal sample. Behaviour Research and Therapy, 34, 283-290. 
doi:10.1016/0005-7967(95)00074-7 
Schmidt, N. B. (1999). Prospective evaluation o f  anxiety sensitiv­
ity. In S. Taylor (Ed.), Anxiety sensitivity—Theory, research, 
and treatment o f  the fea r o f  anxiety (pp. 61-82). Mahwali, NJ: 
Lawrence Erlbaum.
Schmidt, N. B., Eggleston, A. M., W oolaway-Bickel, K., 
Fitzpatrick, K. K., Vasey, M. W., & Richey, J. A. (2007). 
A nxiety Sensitivity Amelioration Training (ASAT): A  lon­
gitudinal primary prevention program targeting cognitive 
vulnerability. Journal o f  Anxiety D isorders, 21, 302-319. 
doi: 10.1016/j.janxdis.2006.06.002 
Schmidt, N. B., Keough, M. E., Mitchell, M. A., Reynolds, E. K., 
MacPherson, L., Zvolensky, M. J., & Lejuez, C. W. (2010). 
Anxiety sensitivity: Prospective prediction o f  anxiety among 
early adolescents. Journal o f  Anxiety Disorders, 24, 503-508. 
doi:10.1016/j.janxdis.2010.03.007 
Schmidt, N. B., Lerew, D. R., & Trakowski, J. H. (1997). Body 
vigilance in panic disorder: Evaluating attention to bodily per­
turbations. Journal o f  Consulting and Clinical Psychology, 65, 
214-220. doi:10.1037/0022-006X.65.2.214
Schmidt, N. B., & Mallott, M. (2006). Evaluating anxiety sensitivity 
and other fundamental sensitivities predicting anxiety symp­
toms and fearful responding to a biological challenge. Behav­
iour Research and Therapy, 44, 1681-1688. doi: 10.1016/j. 
brat.2005.12.001 
Schmidt, N. B., Zvolensky, M. J., & Maner, J. K. (2006). Anxiety 
sensitivity: Prospective prediction o f  panic attacks and Axis 
I pathology. Journal o f  Psychiatric Research, 40, 691-699. 
doi: 10.1016/j.jpsychires.2006.07.009 
Spielberger, C. D., Gorsuch, R. C., & Lushene, R. E. (1970). 
Manual fo r  the State Trait Anxiety Inventory. Palo Alto, CA: 
Consulting Psychologists Press.
Steiger, J. H. (1980). Tests for comparing elements o f  a correlation 
matrix. Psychological Bulletin, 8 7,245-251. doi: 10.1037/003 3- 
2909.87.2.245
Taylor, S. (1996). N ature and measurem ent o f  anxiety sen­
sitivity: R eply to Lilienfeld, Turner, and Jacob (1996). 
Journal o f  Anxiety D isorders, 1 0 ,425-451. doi: 10.1016/0887- 
6185(96)00021-7 
Taylor, S. (Ed.). (1999). Anxiety sensitivity—Theory, research, and 
treatment o f  the fear o f  anxiety. Mahwali, NJ: Lawrence Erl- 
baum.
Taylor, S., & Cox, B. J. (1998). An expanded anxiety sensitivity 
index: Evidence for a hierarchic structure in a clinical sam­
ple. Journal o f  Anxiety Disorders, 12, 463-483. doi: 10.1016/ 
S0887-6185(98)00028-0 
Taylor, S., Koch, W. J., Woody, S., & McLean, P. (1996). Anxi­
ety sensitivity and depression: How are they related? Journal 
o f  Abnormal Psychology, 105, 474-479. doi:10.1037/0021 - 
843X.105.3.474
Taylor, S., Zvolensky, M. J., Cox, B. J., Deacon, B., Heiniberg, R. G., 
Ledley, D. R., . . . Cardenas, S. J. (2007). Robust dimensions 
o f  anxiety sensitivity: Development and initial validation o f 
the Anxiety Sensitivity Index-3. Psychological Assessment, 
19, 176-188. doi:10.1037/1040-3590.19.2.176 
Vormbrock, F., & Neuser, J. (1983). Konstruktion zweier spe­
zifischer Fragebögen zur Erfassung von Angst in sozialen 
Situationen (SANB und SVSS) [German version o f  the 
Fear o f  Negative Evaluation Scale (FNE)]. Diagnostica, 29, 
165-182.
Waller, N. G., & Meehl, P. E. (1998). Multivariate taxometricpro­
cedures: Distinguishing types from  continua. Thousand Oaks, 
CA: SAGE.
Watson, D., & Friend, R. (1969). Measurement o f  social-evaluative 
anxiety. Journal o f  Consulting and Clinical Psychology 33, 
448-457. doi:10.1037/h0027806 
Watzke, B., Ruddel, H., Jurgensen, R., Koch, U., Kriston, L., 
Grothgar, B., & Schulz, H. (2010). Effectiveness o f systematic 
treatm ent selection for psychodynam ic and cognitive- 
behavioural therapy: Randomised controlled trial in rou­
tine mental healthcare. British Journal o f  Psychiatry, 197, 
96-105. doi: 10.1192/bjp.bp.109.072835.
Wilson, K. A., & Hayward, C. (2006). Unique contributions ofanxi- 
ety sensitivity to avoidance: A  prospective study in adolescents.
100 Assessment 19( 1)
Behaviour Research and Therapy, 44, 601-609. doi: 10.1016/ 
j.brat.2005.04.005 
World Health Organization. (1992). The ICD-10 classification o f  men­
tal and behavioural disorders— Clinical descriptions and diagnos­
tic guidelines. Geneva, Switzerland: World Health Organization. 
Z inbarg, R. E., Barlow, D. H., & Brown, T. A. (1997). 
H ierarchical structure and general factor saturation o f  the 
A nxiety Sensitivity Index: Evidence and im plications. 
P sychological Assessm ent, 9, 277-284. do i:10 .1037/1040- 
3590.9.3.277
Zinbarg, R. E., Brown, T. A., Barlow, D. H., & Rapee, R. M. 
(2001). A nxiety sensitivity, panic, and depressed mood: A 
reanalysis teasing apart the contributions o f  the two levels 
in the hierarchical structure o f the Anxiety Sensitivity Index. 
Journal o f  Abnorm al Psychology, 110, 372-377. doi: 10.1037/ 
0021-843X.110.3.372 
Zvolensky, M. 1, & Forsyth, J. P. (2002). Anxiety sensitivity 
dimensions in the prediction o f body vigilance and emotional 
avoidance. Cognitive Therapy and Research, 26, 449-460. doi: 
10.1023/A: 1016223716132
